Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07550881Phase 2Not Yet Recruiting

Intranasal Dexmedetomidine for Acute Anxiety State in Adults

Role: collaborator

NCT06374966Not Yet Recruiting

Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

Role: collaborator

NCT05777876Not ApplicableUnknown

Early Identification of TRD and Construction and Clinical Validation of NTBS Precision Technology

Role: collaborator

NCT04915001Completed

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

All 5 trials loaded